Abstract
COVID-19 is challenging many societal institutions, including our criminal justice systems. Some have proposed or enacted (e.g. the State of New Jersey) reductions in the jail and/or prison populations. We present a mathematical model to explore the epidemiological impact of such interventions in jails and contrast them with the consequences of maintaining unaltered practices. We consider infection risk and likely in-custody deaths, and estimate how within-jail dynamics lead to spill-over risks, not only affecting incarcerated people, but increasing exposure, infection, and death rates for both corrections officers, and the broader community beyond the justice system. We show that, given a typical jail-community dynamic, operating in a business-as-usual way will result in significant and rapid loss of life. Large scale reductions in arrest and speeding of releases are likely to save the lives of incarcerated people, jail staff, and the community at large.
Competing Interest Statement
AH and BM are employed as researchers at an advocacy organization, in collaboration with coauthors who are unpaid members of that same advocacy organization (EL, KL, KM, NF). That organization had no role in determining how the study was conducted, or the results obtained. Further, EL and NF are currently acting as pro bono expert witnesses for legal cases based on the results of this work.
Funding Statement
EL was supported by the CDC Cooperative Agreement RFA-CK-17-001-Modeling Infectious Diseases in Healthcare Program (MInD-Healthcare).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Parameters and curve-fit updated for US-based cases.
Data Availability
The code necessary to run the models is available upon request from the authors, and the equations and parameter values necessary for the results of the manuscript are contained within it.
